Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT07707986Phase 1Not yet recruiting
Phase 1, single-arm trial in surgical wound, sponsored by West Kazakhstan Marat Ospanov Medical University. Primary endpoint: Number of Participants With Treatment-Emergent Adverse Events at Day 28. Planned start Sep 2026; status: not yet recruiting.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT07707986.